Curcumin PLGA Nanoparticles RA-10-6052 (continuation RA-12-6018)

StatusFinished
Effective start/end date1/01/1131/12/12

Funding

  • SignPath Pharmaceuticals, Inc.: $185,250.00

Keywords

  • Biotechnology & Drug Development